trending Market Intelligence /marketintelligence/en/news-insights/trending/rz4awbgtq1sdqkv1vtytja2 content esgSubNav
In This List

OWC Pharmaceutical appoints chief scientific officer

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


OWC Pharmaceutical appoints chief scientific officer

OWC Pharmaceutical Research Corp. appointed Oron Zeevi as chief scientific officer.

Previously, Zeevi served as chief scientific officer at NeuroDerm Ltd., which was bought by Mitsubishi Tanabe Pharma Corp. for $1.1 billion in 2017.